Clinical Trials Browser

Phase 3 × Patient Preference × Ado-Trastuzumab Emtansine × Clear all

NCT05415215 2026-02-10

ProHer

Phase 3 Completed

346 enrolled 20 charts

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms